|
| 38072324 | Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019. | Int J Radiat Oncol Biol Phys | 2024 |
| 35306541 | Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. | Prostate Cancer Prostatic Dis | 2023 |
| 37662703 | Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer. | Eur Urol Open Sci | 2023 |
| 37550448 | Genomic Characterization of Aggressive Breast Cancer in Younger Women. | Ann Surg Oncol | 2023 |
| 37537835 | Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act. | Cancer Med | 2023 |
| 35688664 | The Impact of a Statewide Active Surveillance Initiative: A Roadmap for Increasing Active Surveillance Utilization Nationwide. | Eur Urol | 2023 |
| 37120487 | ASO Author Reflections: Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders. | Ann Surg Oncol | 2023 |
| 37017832 | Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups. | Ann Surg Oncol | 2023 |
| 37236698 | Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis. | Lancet Digit Health | 2023 |
| 37003878 | Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. | Urol Oncol | 2023 |
| 37003085 | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022. | Eur J Cancer | 2023 |
| 37477913 | Unique Spectrum of Activating BRAF Alterations in Prostate Cancer. | Clin Cancer Res | 2023 |
| 37262399 | Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer. | JCO Oncol Pract | 2023 |
| 36522269 | Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome. | Clin Genitourin Cancer | 2023 |
| 36720765 | Prevalence of Financial Toxicity Among Hispanic Cancer Survivors: A Nationally Representative Pan-Cancer Analysis. | J Gen Intern Med | 2023 |
| 36785859 | Disparities in access to cancer diagnostics in ASEAN member countries. | Lancet Reg Health West Pac | 2023 |
| 36693227 | Racism Does Not Cause Prostate Cancer, It Causes Prostate Cancer Death. | J Clin Oncol | 2023 |
| 36400666 | Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis. | Urol Oncol | 2023 |
| 36399692 | Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality. | JCO Oncol Pract | 2023 |
| 36609003 | Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. | Eur Urol | 2023 |
| 36710133 | Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. | Eur Urol Oncol | 2023 |
| 36494221 | Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. | Eur Urol | 2023 |
| 36630135 | Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis. | JAMA Netw Open | 2023 |
| 33303244 | Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer. | Eur Urol | 2022 |
| 35671868 | Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2022 |
| 35638091 | Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race. | Eur Urol Open Sci | 2022 |
| 36778922 | The right to be screened: Identifying and addressing inequities in genetic screening. | Lancet Reg Health Am | 2022 |
| 35933540 | ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups. | Ann Surg Oncol | 2022 |
| 36066378 | Racial disparities in Black men with prostate cancer: A literature review. | Cancer | 2022 |
| 35953743 | Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups. | Ann Surg Oncol | 2022 |
| 36344844 | Endocrine resistance and breast cancer plasticity are controlled by CoREST. | Nat Struct Mol Biol | 2022 |
| 36187555 | Genomic alterations predictive of poor clinical outcomes in pan-cancer. | Oncotarget | 2022 |
| 35877007 | Shared burden: the association between cancer diagnosis, financial toxicity, and healthcare cost-related coping mechanisms by family members of non-elderly patients in the USA. | Support Care Cancer | 2022 |
| 35190652 | Racial disparities in treatment delay among younger men with prostate cancer. | Prostate Cancer Prostatic Dis | 2022 |
| 35245846 | DNA repair and immune checkpoint blockade response. | Cancer Genet | 2022 |
| 35022600 | Clinicogenomic characterization of prostate cancer liver metastases. | Prostate Cancer Prostatic Dis | 2022 |
| 34962644 | Looking beyond the Western lens: How culture and identity influence perceptions of empathy in patient-clinician relationships. | Cancer | 2022 |
| 35333787 | Left Out: Disparities in Access to Care Among Foreign-Born Populations and Implications for Hospital-Based Studies. | Am J Gastroenterol | 2022 |
| 35230441 | Racial Differences in Genomic Profiles of Breast Cancer. | JAMA Netw Open | 2022 |
| 35194179 | Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysis. | Prostate Cancer Prostatic Dis | 2022 |
| 34709962 | Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic Groups. | JCO Oncol Pract | 2022 |
| 34694897 | Reporting of Racial Health Disparities Research: Are We Making Progress? | J Clin Oncol | 2022 |
| 34624364 | Naming the Problem: Publishing Trends within in Urology on Race, Health Disparities and Structural Racism. | Urology | 2022 |
| 34418408 | Examining the Racial Disparities in Prostate Cancer. | Urology | 2022 |
| 34563484 | Association of race with receipt of definitive therapy for high risk prostate cancer in older men. | J Geriatr Oncol | 2022 |
| 34446369 | Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel. | Eur Urol Oncol | 2022 |
| 34127801 | Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. | Prostate Cancer Prostatic Dis | 2022 |
| 32320768 | Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: AÂ single-center case series and national database comparison. | J Am Acad Dermatol | 2021 |
| 33880936 | Is Medicaid expansion associated with increases in palliative treatments for metastatic cancer? | J Comp Eff Res | 2021 |
| 33905530 | Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial. | Cancer | 2021 |